These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 185941

  • 1. The adjuvant effect of microbial products on the immune response.
    White RG.
    Annu Rev Microbiol; 1976; 30():579-600. PubMed ID: 185941
    [No Abstract] [Full Text] [Related]

  • 2. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I, Kanetsuna F, Taniyama T, Yamamura Y, Hori M.
    Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
    [Abstract] [Full Text] [Related]

  • 3. The role and specificity of bordetella lipopolysaccharide in immune reactions.
    Pusztai Z, Csizér Z, Joó I.
    Z Immunitatsforsch Allerg Klin Immunol; 1971 Mar; 141(2):129-40. PubMed ID: 4323220
    [No Abstract] [Full Text] [Related]

  • 4. Adjuvant-induced selective recruitment of specifically reactive lymphocytes: a probable mechanism of adjuvant action.
    Emeson EE.
    J Immunol; 1980 May; 124(5):2222-30. PubMed ID: 6245138
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Gram-positive bacteria as adjuvants (author's transl)].
    Hahn H.
    Immun Infekt; 1978 Jun; 6(3):123-6. PubMed ID: 96006
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The orientation of the adjuvant activities of Salmonella typhosa lipopolysaccharide and lentinan.
    Dresser DW, Phillips JM.
    Immunology; 1974 Nov; 27(5):895-902. PubMed ID: 4548044
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pharmacological aspects of immunostimulants].
    Eichelberg D, Schmutzler W.
    Immun Infekt; 1983 Jun; 11(4):109-22. PubMed ID: 6085319
    [Abstract] [Full Text] [Related]

  • 13. Possible reasons for the inefficiency of Gram-negative bacterial vaccines.
    Wardlaw AC.
    Prog Immunobiol Stand; 1971 Jun; 5():508-12. PubMed ID: 4349834
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum containing endotoxin-induced tumour necrosis factor substitutes for helper T cells.
    Hoffmann MK, Green S, Old LJ, Oettgen HF.
    Nature; 1976 Sep 30; 263(5576):416-7. PubMed ID: 787802
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Immunopotentiation: aims, ways, results].
    Riethmüller G.
    Internist (Berl); 1975 Oct 30; 16(10):466-70. PubMed ID: 54347
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.